General Information of the Compound
Compound ID
CP0117201
Compound Name
Ft-2102
    Show/Hide
Synonyms
(S)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile
0T4IMT8S5Z
1887014-12-1
2-Pyridinecarbonitrile, 5-(((1S)-1-(6-chloro-1,2-dihydro-2-oxo-3-quinolinyl)ethyl)amino)-1,6-dihydro-1-methyl-6-oxo-
5-(((1S)-1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile
CS-0080183
FT-2102
HY-114226
NEQYWYXGTJDAKR-JTQLQIEISA-N
Olutasidenib
Olutasidenib [USAN]
SCHEMBL17603134
UNII-0T4IMT8S5Z
    Show/Hide
Structure
Formula
C18H15ClN4O2
Molecular Weight
354.797
Canonical SMILES
C[C@H](Nc1ccc(C#N)n(C)c1=O)c1cc2cc(Cl)ccc2[nH]c1=O
    Show/Hide
InChI
InChI=1S/C18H15ClN4O2/c1-10(21-16-6-4-13(9-20)23(2)18(16)25)14-8-11-7-12(19)3-5-15(11)22-17(14)24/h3-8,10,21H,1-2H3,(H,22,24)/t10-/m0/s1
    Show/Hide
InChIKey
NEQYWYXGTJDAKR-JTQLQIEISA-N
CAS
1887014-12-1
Physicochemical Property
logP
2.92498
Rotatable Bonds
3
Heavy Atom Count
25
Polar Areas
90.68
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
5
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 118955396
ChEMBL ID
CHEMBL4297610
DrugBank ID
DB16267
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02997, Isocitrate dehydrogenase [NADP] cytoplasmic
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000102 U-87MG ATCC Homo sapiens (Human)  4
1
IC50 = 6 nM
   TI
   LI
   LO
   TS
2
IC50 = 9 nM
   TI
   LI
   LO
   TS
3
IC50 = 39 nM
   TI
   LI
   LO
   TS
4
IC50 = 42 nM
   TI
   LI
   LO
   TS
CL000067 HCT 116 Homo sapiens (Human)  2
1
IC50 = 21 nM
   TI
   LI
   LO
   TS
2
IC50 = 94 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 21.2 nM
2 IC50 = 114 nM
3 IC50 = 22400 nM
Clinical Information about the Compound
Drug 1 ( Olutasidenib )
Drug Name Olutasidenib
Company Rigel/Forma
Indication
Acute myeloid leukaemia
Approved
Glioma
Phase 1/2
Acute myeloid leukaemia
Phase 1
Myelodysplastic syndrome
Phase 1
Target(s)
Oxalosuccinate decarboxylase (IDH1)
Inhibitor